TRADES
Latest Trades
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKK 29 Dec 2022 Buy TDOC TELADOC INC 166,294 0.0689
ARKK 29 Dec 2022 Buy ZM ZOOM VIDEO COMMUNICATIONS 56,808 0.0670
ARKK 29 Dec 2022 Buy TSLA TESLA INC 22,514 0.0473
ARKK 29 Dec 2022 Buy ROKU ROKU INC 32,011 0.0226
ARKK 29 Dec 2022 Sell MTLS MATERIALISE NV 142,169 0.0218
ARKG 28 Dec 2022 Sell FATE FATE THERAPEUTICS INC 30,693 0.0166
ARKG 28 Dec 2022 Buy CRSP CRISPR THERAPEUTICS AG 7,389 0.0160
ARKG 28 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 3,999 0.0081
ARKK 28 Dec 2022 Buy TSLA TESLA INC 17,960 0.0345
ARKK 28 Dec 2022 Sell FATE FATE THERAPEUTICS INC 142,110 0.0244
ARKK 28 Dec 2022 Sell MTLS MATERIALISE NV 44,042 0.0065
ARKF 27 Dec 2022 Buy COIN COINBASE GLOBAL INC 6,179 0.0314
ARKF 27 Dec 2022 Sell Z ZILLOW GROUP INC 4,215 0.0209
ARKG 27 Dec 2022 Sell FATE FATE THERAPEUTICS INC 60,069 0.0313
ARKG 27 Dec 2022 Buy CRSP CRISPR THERAPEUTICS AG 10,787 0.0231
ARKG 27 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 1,198 0.0023
ARKG 27 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 1,498 0.0017
ARKK 27 Dec 2022 Sell FATE FATE THERAPEUTICS INC 277,522 0.0463
ARKK 27 Dec 2022 Buy TSLA TESLA INC 25,147 0.0462
ARKK 27 Dec 2022 Sell MTLS MATERIALISE NV 3,946 0.0006
ARKF 23 Dec 2022 Buy RBLX ROBLOX CORP 37,034 0.1460
ARKF 23 Dec 2022 Sell Z ZILLOW GROUP INC 10,031 0.0507
ARKF 23 Dec 2022 Buy COIN COINBASE GLOBAL INC 5,000 0.0257
ARKG 23 Dec 2022 Sell EXAS EXACT SCIENCES CORP 9,036 0.0239
ARKG 23 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 8,143 0.0167
ARKG 23 Dec 2022 Sell FATE FATE THERAPEUTICS INC 29,547 0.0164
ARKG 23 Dec 2022 Buy TDOC TELADOC INC 10,985 0.0131
ARKG 23 Dec 2022 Buy NTLA INTELLIA THERAPEUTICS INC 6,489 0.0114
ARKG 23 Dec 2022 Buy CRSP CRISPR THERAPEUTICS AG 4,012 0.0090
ARKG 23 Dec 2022 Buy VERV VERVE THERAPEUTICS INC 8,794 0.0082
ARKG 23 Dec 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 69,924 0.0058
ARKG 23 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 999 0.0012
ARKK 23 Dec 2022 Buy TSLA TESLA INC 20,458 0.0404
ARKK 23 Dec 2022 Sell FATE FATE THERAPEUTICS INC 136,762 0.0241
ARKK 23 Dec 2022 Sell EXAS EXACT SCIENCES CORP 26,840 0.0225
ARKK 23 Dec 2022 Buy ROKU ROKU INC 6,786 0.0045
ARKF 22 Dec 2022 Sell Z ZILLOW GROUP INC 153,799 0.7474
ARKF 22 Dec 2022 Buy RBLX ROBLOX CORP 154,095 0.5916
ARKF 22 Dec 2022 Buy COIN COINBASE GLOBAL INC 23,509 0.1167
ARKG 22 Dec 2022 Buy TDOC TELADOC INC 18,972 0.0224
ARKG 22 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 6,991 0.0140
ARKG 22 Dec 2022 Buy NTLA INTELLIA THERAPEUTICS INC 5,992 0.0102
ARKG 22 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 7,490 0.0083
ARKG 22 Dec 2022 Buy SLGC SOMALOGIC INC 23,062 0.0024
ARKG 22 Dec 2022 Buy VERV VERVE THERAPEUTICS INC 484 0.0004
ARKG 22 Dec 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,979 0.0002
ARKK 22 Dec 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 26,329 0.0007
ARKF 21 Dec 2022 Sell Z ZILLOW GROUP INC 13,805 0.0707
ARKF 21 Dec 2022 Buy COIN COINBASE GLOBAL INC 11,600 0.0604
ARKF 21 Dec 2022 Buy RBLX ROBLOX CORP 12,131 0.0494
ARKG 21 Dec 2022 Buy NTLA INTELLIA THERAPEUTICS INC 22,278 0.0405
ARKG 21 Dec 2022 Buy VERV VERVE THERAPEUTICS INC 30,695 0.0290
ARKG 21 Dec 2022 Buy SLGC SOMALOGIC INC 200,628 0.0216
ARKG 21 Dec 2022 Sell FATE FATE THERAPEUTICS INC 27,436 0.0176
ARKG 21 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 11,508 0.0139
ARKG 21 Dec 2022 Sell ONVO ORGANOVO HOLDINGS INC 1,473 0.0001
ARKK 21 Dec 2022 Sell FATE FATE THERAPEUTICS INC 130,138 0.0259
ARKK 21 Dec 2022 Buy TSLA TESLA INC 9,952 0.0217
ARKK 21 Dec 2022 Buy ROKU ROKU INC 8,004 0.0054
ARKK 21 Dec 2022 Sell MTLS MATERIALISE NV 22,260 0.0031
ARKK 21 Dec 2022 Buy SQ BLOCK INC 1,932 0.0019
ARKK 21 Dec 2022 Buy ZM ZOOM VIDEO COMMUNICATIONS 486 0.0005
ARKQ 21 Dec 2022 Sell ONVO ORGANOVO HOLDINGS INC 702 0.0001
ARKF 20 Dec 2022 Sell Z ZILLOW GROUP INC 59,600 0.2983
ARKF 20 Dec 2022 Buy ROKU ROKU INC 15,873 0.1012
ARKG 20 Dec 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 898,783 0.0752
ARKG 20 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 18,830 0.0385
ARKG 20 Dec 2022 Sell EXAS EXACT SCIENCES CORP 5,736 0.0151
ARKG 20 Dec 2022 Buy TDOC TELADOC INC 6,092 0.0079
ARKG 20 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 5,493 0.0065
ARKK 20 Dec 2022 Buy TSLA TESLA INC 19,125 0.0421
ARKK 20 Dec 2022 Sell EXAS EXACT SCIENCES CORP 32,910 0.0268
ARKK 20 Dec 2022 Sell MTLS MATERIALISE NV 847 0.0001
ARKF 19 Dec 2022 Sell Z ZILLOW GROUP INC 86,686 0.4480
ARKF 19 Dec 2022 Buy COIN COINBASE GLOBAL INC 48,200 0.2445
ARKF 19 Dec 2022 Buy ROKU ROKU INC 29,532 0.1889
ARKF 19 Dec 2022 Buy RBLX ROBLOX CORP 11,299 0.0441
ARKG 19 Dec 2022 Sell EXAS EXACT SCIENCES CORP 19,893 0.0506
ARKG 19 Dec 2022 Buy TDOC TELADOC INC 16,712 0.0211
ARKG 19 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 7,568 0.0149
ARKG 19 Dec 2022 Buy CRSP CRISPR THERAPEUTICS AG 5,708 0.0124
ARKG 19 Dec 2022 Buy VERV VERVE THERAPEUTICS INC 11,468 0.0103
ARKG 19 Dec 2022 Buy NTLA INTELLIA THERAPEUTICS INC 3,419 0.0059
ARKG 19 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 1,503 0.0017
ARKG 19 Dec 2022 Sell ONVO ORGANOVO HOLDINGS INC 201 0.0000
ARKK 19 Dec 2022 Sell EXAS EXACT SCIENCES CORP 114,174 0.0893
ARKK 19 Dec 2022 Buy ROKU ROKU INC 68,079 0.0446
ARKK 19 Dec 2022 Buy TDOC TELADOC INC 50,037 0.0195
ARKK 19 Dec 2022 Buy BEAM BEAM THERAPEUTICS INC 23,816 0.0144
ARKK 19 Dec 2022 Buy CRSP CRISPR THERAPEUTICS AG 17,738 0.0118
ARKK 19 Dec 2022 Buy VERV VERVE THERAPEUTICS INC 38,421 0.0106
ARKK 19 Dec 2022 Buy SQ BLOCK INC 9,372 0.0085
ARKK 19 Dec 2022 Buy NTLA INTELLIA THERAPEUTICS INC 10,867 0.0057
ARKK 19 Dec 2022 Buy TWST TWIST BIOSCIENCE CORP 4,611 0.0016
ARKQ 19 Dec 2022 Buy TSLA TESLA INC 27,494 0.4942
ARKQ 19 Dec 2022 Sell DE DEERE & CO 5,705 0.2976
ARKQ 19 Dec 2022 Sell CAT CATERPILLAR INC 7,112 0.2010
ARKQ 19 Dec 2022 Sell ONVO ORGANOVO HOLDINGS INC 96 0.0000
ARKG 16 Dec 2022 Sell EXAS EXACT SCIENCES CORP 33,422 0.0863
ARKG 16 Dec 2022 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 69,291 0.0216
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.